Keywords: |
unclassified drug; nonhuman; animal cell; animal; metabolism; in vitro study; drug effect; central nervous system; drug receptor binding; brain; drug derivative; cattle; radioisotope; morphine; oligopeptides; mu opiate receptor; receptors, opioid, mu; pharmacokinetics; in vitro; opiate receptor; enkephalin[2,5 dextro penicillamine]; mu 1 opiate receptor; brain level; drug interaction; delta opiate receptor; receptors, opioid, delta; oligopeptide; thalamus; enkephalin; leucine enkephalin; brain chemistry; receptors, opioid; priority journal; article; enkephalin derivative; enkephalin, leucine-2-alanine; support, u.s. gov't, p.h.s.; enkephalins; enkephalin, d-penicillamine (2,5)-; enkephalin, leucine; enkephalin, leucine 2 alanine; enkephalin[2 alanine 5 leucine]; tyrosyl seryl glycyl phenylalanyl leucyl threonine; tyrosyl-seryl-glycyl-phenylalanyl-leucyl-threonine; enkephalin derivative h 3; enkephalin, d penicillamine (2,5)
|